Heikki Joensuu, Piotr Rutkowski, Toshirou Nishida, Sonja E Steigen, Peter Brabec, Lukas Plank, Bengt Nilsson, Chiara Braconi, Andrea Bordoni, Magnus K Magnusson, Jozef Sufliarsky, Massimo Federico, Jon G Jonasson, Isabelle Hostein, Pierre-Paul Bringuier, Jean-Francois Emile
PURPOSE: Mutated KIT and platelet-derived growth factor alpha gene (PDGFRA) drive GI stromal tumor (GIST) oncogenesis, but the clinical significance of their single mutations is known incompletely. PATIENTS AND METHODS: We identified 11 population-based series of patients with GIST through a literature search and pooled individual data from 3,067 patients treated with macroscopically complete tumor excision. Mutation analysis was done from 1,505 tumors. We analyzed associations between KIT and PDGFRA mutations and recurrence-free survival (RFS) in the subsets in which patients were treated with surgery alone...
February 20, 2015: Journal of Clinical Oncology